Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Indivior Pharmaceuticals (INDV) Prepaid Assets (2023 - 2025)

Indivior Pharmaceuticals has reported Prepaid Assets over the past 3 years, most recently at $16.0 million for Q4 2025.

  • Quarterly results put Prepaid Assets at $16.0 million for Q4 2025, down 23.81% from a year ago — trailing twelve months through Dec 2025 was $16.0 million (down 23.81% YoY), and the annual figure for FY2025 was $16.0 million, down 23.81%.
  • Prepaid Assets for Q4 2025 was $16.0 million at Indivior Pharmaceuticals, down from $30.0 million in the prior quarter.
  • Over the last five years, Prepaid Assets for INDV hit a ceiling of $56.0 million in Q1 2025 and a floor of $16.0 million in Q4 2025.
  • Median Prepaid Assets over the past 3 years was $25.5 million (2024), compared with a mean of $32.5 million.
  • Biggest five-year swings in Prepaid Assets: crashed 59.62% in 2024 and later fell 23.81% in 2025.
  • Indivior Pharmaceuticals' Prepaid Assets stood at $52.0 million in 2023, then crashed by 59.62% to $21.0 million in 2024, then fell by 23.81% to $16.0 million in 2025.
  • The last three reported values for Prepaid Assets were $16.0 million (Q4 2025), $30.0 million (Q3 2025), and $20.0 million (Q2 2025) per Business Quant data.